These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2477864)

  • 1. A spirohydantoin derivative of oxymorphone: an agonist with delayed antagonist activity.
    Alexander GJ; Chatterjie N; Wisniewski HM
    Pharmacol Biochem Behav; 1989 Apr; 32(4):939-43. PubMed ID: 2477864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diastereoisomeric N-tetrahydrofurfurylnoroxymorphones with opioid agonist--antagonist properties.
    Merz H; Stockhaus K; Wick H
    J Med Chem; 1977 Jun; 20(6):844-6. PubMed ID: 69027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxymorphazone: a long-acting opiate analgesic.
    Ling GS; Galetta S; Pasternak GW
    Cell Mol Neurobiol; 1984 Mar; 4(1):1-13. PubMed ID: 6204757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxymorphone-naltrexonazine, a mixed opiate agonist-antagonist.
    Galetta S; Hahn EF; Nishimura S; Pasternak GW
    Life Sci; 1987 Aug; 41(6):783-7. PubMed ID: 2441221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons of the analgesic effects of oral and intramuscular oxymorphone and of intramuscular oxymorphone and morphine in patients with cancer.
    Beaver WT; Wallenstein SL; Houde RW; Rogers A
    J Clin Pharmacol; 1977 Apr; 17(4):186-98. PubMed ID: 66240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine analgesia after intrathecal administration of a narcotic agonist, chloroxymorphamine and antagonist, chlornaltrexamine.
    Larson AA; Armstrong MJ
    Eur J Pharmacol; 1980 Nov; 68(1):25-31. PubMed ID: 6161013
    [No Abstract]   [Full Text] [Related]  

  • 7. Irreversible and reversible narcotic agonists: discriminative and analgesic effects of buprenorphine, oxymorphazone, and morphine.
    France CP; Jacobson AE; Woods JH
    NIDA Res Monogr; 1984 Mar; 49():136-42. PubMed ID: 6207431
    [No Abstract]   [Full Text] [Related]  

  • 8. Receptor binding and analgesic properties of oxymorphazone.
    Galetta S; Ling GS; Wolfin L; Pasternak GW
    Life Sci; 1982 Sep 20-27; 31(12-13):1389-92. PubMed ID: 6183551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irreversible opiate agonists and antagonists. IV. Analgesic actions of 14-hydroxydihydromorphinone hydrazones.
    Williams CL; Bodnar RJ; Clark JE; Hahn EF; Burks TF; Pasternak GW
    J Pharmacol Exp Ther; 1988 Apr; 245(1):8-12. PubMed ID: 2452249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological studies with an alkylating narcotic agonist, chloroxymorphamine, and antagonist, chlornaltrexamine.
    Caruso TP; Larson DL; Portoghese PS; Takemori AE
    J Pharmacol Exp Ther; 1980 Jun; 213(3):539-44. PubMed ID: 6162947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloroxymorphamine, and opioid receptor site-directed alkylating agent having narcotic agonist activity.
    Caruso TP; Takemori AE; Larson DL; Portoghese PS
    Science; 1979 Apr; 204(4390):316-8. PubMed ID: 86208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 7-spirobenzocyclohexyl derivatives of naltrexone, oxymorphone, and hydromorphone as selective opioid receptor ligands.
    Fang X; Larson DL; Portoghese PS
    J Med Chem; 1997 Sep; 40(19):3064-70. PubMed ID: 9301669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Social conflict analgesia: studies on naloxone antagonism and morphine cross-tolerance in male DBA/2 mice.
    Rodgers RJ; Randall JI
    Pharmacol Biochem Behav; 1985 Nov; 23(5):883-7. PubMed ID: 2417263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the analgesic effect of oxymorphone by rectal suppository and intramuscular injection in patients with postoperative pain.
    Beaver WT; Feise GA
    J Clin Pharmacol; 1977; 17(5-6):276-91. PubMed ID: 67128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analgesic activity of various morphine derivatives on the Afghan pika (Ochotona rufescens rufescens): tolerance of the acute effects of morphine].
    Puget A
    Zentralbl Veterinarmed A; 1980 Apr; 27(2):157-64. PubMed ID: 6157270
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-acting opiate agonists and antagonists: 14-hydroxydihydromorphinone hydrazones.
    Pasternak GW; Hahn EF
    J Med Chem; 1980 Jun; 23(6):674-6. PubMed ID: 6156240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].
    Ananthan S; Khare NK; Saini SK; Seitz LE; Bartlett JL; Davis P; Dersch CM; Porreca F; Rothman RB; Bilsky EJ
    J Med Chem; 2004 Mar; 47(6):1400-12. PubMed ID: 14998329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of quaternary naloxone on the increased naloxone potency induced by morphine.
    Wong CL; Wai MK
    Clin Exp Pharmacol Physiol; 1984; 11(5):467-71. PubMed ID: 6084569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid agonist and antagonist activities of peripherally selective derivatives of naltrexamine and oxymorphamine.
    Botros S; Lipkowski AW; Larson DL; Stark PA; Takemori AE; Portoghese PS
    J Med Chem; 1989 Sep; 32(9):2068-71. PubMed ID: 2475628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of morphine, methadone, hydromorphone or oxymorphone on the thermal threshold, following intravenous or buccal administration to cats.
    Pypendop BH; Shilo-Benjamini Y; Ilkiw JE
    Vet Anaesth Analg; 2016 Nov; 43(6):635-642. PubMed ID: 27723230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.